EUVIMEDEUVIMED entdecken
Crossref

Enhanced Tumor Targeting of Radiolabeled Mouse/Human Chimeric Anti-Tn Antibody in Losartan-Treated Mice Bearing Tn-Expressing Lung Tumors

Marcos Tassano iD, Ximena Camacho, Teresa Freire, Carolina Perroni, Valeria da Costa, Mirel Cabrera, Maria Fernanda García, Marcelo Fernandez, Juan Pablo Gambini, Pablo Cabral, Eduardo Osinaga

Cancer Biotherapy and Radiopharmaceuticals · 2024

DOI: 10.1089/cbr.2023.0138 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Biotherapy and Radiopharmaceuticals, 2024. Verfasst von Marcos Tassano und 10 weiteren Autor:innen. Beteiligte Einrichtung: Area de Radiofarmacia, Centro de Investigaciones Nucleares, Facultad de Ciencias, Universidad de la República, Montevideo, Uruguay. Hauptthemen laut MEDLINE: Lung Neoplasms, Losartan, Iodine Radioisotopes, Antibodies, Monoclonal. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 68 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lung NeoplasmsLosartanIodine RadioisotopesAntibodies, MonoclonalAnimalsMiceHumansTissue DistributionTechnetiumRadiopharmaceuticalsCell Line, TumorFemaleTumor Protein, Translationally-Controlled 1

Stichwörter der Autor:innen

131I99mTcChi-TnLosartanbiodistribution

Substanzen

LosartanIodine RadioisotopesAntibodies, MonoclonalIodine-131TechnetiumRadiopharmaceuticalsTpt1 protein, mouseTumor Protein, Translationally-Controlled 1

Autor:innen und Institutionen

  • Area de Radiofarmacia, Centro de Investigaciones Nucleares, Facultad de Ciencias, Universidad de la República, Montevideo, Uruguay.
  • Laboratorio de Inmunomodulacion y Desarrollo de Vacunas, Departamento de Inmunobiología, Facultad de Medicina, Universidad de La República, Montevideo, Uruguay.
  • Centro de Medicina Nuclear e Imagenología Molecular, Hospital de Clínicas, Facultad de Medicina, Universidad de la República, Montevideo, Uruguay.
  • Laboratorio de Glicobiología e Inmunología Tumoral, Institut Pasteur de Montevideo, Montevideo, Uruguay.

ORCID-Profile: Marcos Tassano

Zitieren

APA

Tassano, M., Camacho, X., Freire, T., Perroni, C., da Costa, V., Cabrera, M., García, M. F., Fernandez, M., Gambini, J. P., Cabral, P., & Osinaga, E. (2024). Enhanced Tumor Targeting of Radiolabeled Mouse/Human Chimeric Anti-Tn Antibody in Losartan-Treated Mice Bearing Tn-Expressing Lung Tumors. Cancer Biotherapy and Radiopharmaceuticals. https://doi.org/10.1089/cbr.2023.0138

Vancouver

Tassano M, Camacho X, Freire T, Perroni C, da Costa V, Cabrera M, et al. Enhanced Tumor Targeting of Radiolabeled Mouse/Human Chimeric Anti-Tn Antibody in Losartan-Treated Mice Bearing Tn-Expressing Lung Tumors. Cancer Biotherapy and Radiopharmaceuticals. 2024. doi:10.1089/cbr.2023.0138

BibTeX
@article{Tassano2024,
  author = {Tassano, Marcos and Camacho, Ximena and Freire, Teresa and Perroni, Carolina and da Costa, Valeria and Cabrera, Mirel and García, Maria Fernanda and Fernandez, Marcelo and Gambini, Juan Pablo and Cabral, Pablo and Osinaga, Eduardo},
  title = {Enhanced Tumor Targeting of Radiolabeled Mouse/Human Chimeric Anti-Tn Antibody in Losartan-Treated Mice Bearing Tn-Expressing Lung Tumors},
  journal = {Cancer Biotherapy and Radiopharmaceuticals},
  year = {2024},
  doi = {10.1089/cbr.2023.0138}
}
Kostenlos starten →